| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AMEPRE.2007.09.005 |
| P698 | PubMed publication ID | 18021912 |
| P50 | author | Dorothy Hatsukami | Q87445426 |
| P2093 | author name string | Stephen S Hecht | |
| Jon O Ebbert | |||
| Irina Stepanov | |||
| Rachel M Feuer | |||
| P433 | issue | 6 Suppl | |
| P304 | page(s) | S368-78 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | American Journal of Preventive Medicine | Q4744265 |
| P1476 | title | Changing smokeless tobacco products new tobacco-delivery systems | |
| P478 | volume | 33 |
| Q36956988 | A content analysis of smokeless tobacco coverage in U.S. newspapers and news wires |
| Q39567870 | A longitudinal, naturalistic study of U.S. smokers' trial and adoption of snus |
| Q33629221 | A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: changes in smoking behavior and readiness to quit |
| Q39782980 | Advertising Receptivity and Youth Initiation of Smokeless Tobacco |
| Q55001844 | Alternative tobacco product use and smoking cessation: a national study. |
| Q42935481 | Analysis of 23 polycyclic aromatic hydrocarbons in smokeless tobacco by gas chromatography-mass spectrometry |
| Q41869884 | Analysis of hydrazine in smokeless tobacco products by gas chromatography-mass spectrometry |
| Q35110020 | Animal models to assess the abuse liability of tobacco products: effects of smokeless tobacco extracts on intracranial self-stimulation. |
| Q42952162 | Are Australian smokers interested in using low-nitrosamine smokeless tobacco for harm reduction? |
| Q47107182 | Beyond the brotherhood: Skoal Bandits' role in the evolution of marketing moist smokeless tobacco pouches |
| Q34556938 | Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products. |
| Q37637592 | Brief, instructional smokeless tobacco use among cigarette smokers who do not intend to quit: a pilot randomized clinical trial |
| Q64124422 | Characteristics of the Tobacco User Adult Cohort in Urban and Rural Ohio |
| Q37010735 | Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products |
| Q33586354 | Cigarette smokers' use of unconventional tobacco products and associations with quitting activity: findings from the ITC-4 U.S. cohort |
| Q35997407 | Delivery of nicotine in an extract of a smokeless tobacco product reduces its reinforcement-attenuating and discriminative stimulus effects in rats |
| Q47132274 | Determination of Aflatoxin B1 in Smokeless Tobacco Products by Use of UHPLC-MS/MS. |
| Q38883915 | Differences in the Bacteriome of Smokeless Tobacco Products with Different Oral Carcinogenicity: Compositional and Predicted Functional Analysis |
| Q34715402 | Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study |
| Q57380598 | Epidemiology of Tobacco Use |
| Q33759588 | Evaluating oral noncombustible potential-reduced exposure products for smokers. |
| Q45248763 | Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specificN-nitrosamines |
| Q52300285 | Has Marlboro hijacked tobacco harm reduction? |
| Q28831487 | High levels of tobacco-specific N-nitrosamines and nicotine in Chaini Khaini, a product marketed as snus |
| Q35821002 | Immunochromatographic Assessment of Salivary Cotinine and Its Correlation With Nicotine Dependence in Tobacco Chewers |
| Q24244287 | Interventions to reduce harm from continued tobacco use |
| Q36689837 | Is snus the same as dip? Smokers' perceptions of new smokeless tobacco advertising |
| Q36929832 | Levels of (S)-N'-nitrosonornicotine in U.S. tobacco products. |
| Q45044780 | Naturalistic assessment of demand for cigarettes, snus, and nicotine gum. |
| Q33943746 | New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. |
| Q46744251 | Nicotine addiction: past, present and future. Marian Fischman lecture given at the 2007 meeting of CPDD. |
| Q40522556 | Perceived Health Risks of Snus and Medicinal Nicotine Products |
| Q38651228 | Prevalence and Factors Associated with Smokeless Tobacco Use, 2014-2016. |
| Q83433812 | Prevalence of trial of snus products among adult smokers |
| Q33511361 | Review of epidemiologic data on the debate over smokeless tobacco's role in harm reduction |
| Q35819352 | Risk perceptions of smokeless tobacco among adolescent and adult users and nonusers |
| Q36078466 | Smokeless tobacco marketing and sales practices in Appalachian Ohio following federal regulations |
| Q38825678 | Smokeless tobacco products harbor diverse bacterial microbiota that differ across products and brands. |
| Q37551886 | Smokeless tobacco: a gateway to smoking or a way away from smoking |
| Q30491305 | Surveillance indicators for potential reduced exposure products (PREPs): developing survey items to measure awareness. |
| Q37024750 | The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US |
| Q90089044 | The acceptability of smokeless tobacco products depends on nicotine levels |
| Q34518686 | The changing tobacco landscape: What dental professionals need to know |
| Q39548958 | The chemical composition of smokeless tobacco: a survey of products sold in the United States in 2006 and 2007. |
| Q46654621 | The debate over weight- versus price-based taxation of snuff in the United States' state legislatures |
| Q34023539 | The use of snus for quitting smoking compared with medicinal products. |
| Q35624469 | Tobacco and nicotine product testing |
| Q53089544 | Tobacco industry consumer research on smokeless tobacco users and product development. |
| Q58120394 | Tobacco product transition patterns in rural and urban cohorts: Where do dual users go? |
| Q40843170 | Trends and Factors Related to Smokeless Tobacco Use in the United States |
| Q46385886 | Trends in the use and advertising of discount versus premium snuff |
| Q38983454 | Validation of a Measure of Normative Beliefs About Smokeless Tobacco Use. |
| Q28267832 | Will chronic e-cigarette use cause lung disease? |
Search more.